BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
66 results:

  • 1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
    Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal liver Metastases.
    Boyev A; Tzeng CD; Maki H; Arvide EM; Mrema DE; Jain AJ; Haddad A; Lendoire M; Malik N; Odisio BC; Chun YS; Tran Cao HS; Vauthey JN; Newhook TE
    Ann Surg Oncol; 2024 Apr; 31(4):2547-2556. PubMed ID: 38148351
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An NFATc1/SMAD3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evolution of treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology.
    Capuozzo M; Santorsola M; Landi L; Granata V; Perri F; Celotto V; Gualillo O; Nasti G; Ottaiano A
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499450
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. smad4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal cancer Growth, and Metastasis.
    Loevenich LP; Tschurtschenthaler M; Rokavec M; Silva MG; Jesinghaus M; Kirchner T; Klauschen F; Saur D; Neumann J; Hermeking H; Jung P
    Cancer Res; 2022 Dec; 82(24):4604-4623. PubMed ID: 36219392
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Apoptotic and Anti-metastatic Effects of Atractylodes lancea (Thunb.) DC. in a Hamster Model of Cholangiocarcinoma.
    Sonsomnuek P; Tarasuk M; Plengsuriyakarn T; Boonprasert K; Na-Bangchang K
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3093-3101. PubMed ID: 36172672
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal liver Metastases.
    Newhook TE; Overman MJ; Chun YS; Dasari A; Tzeng CD; Cao HST; Raymond V; Parseghian C; Johnson B; Nishioka Y; Kawaguchi Y; Uppal A; Vreeland TJ; Jaimovich A; Arvide EM; Cristo JV; Wei SH; Raghav KP; Morris VK; Lee JE; Kopetz S; Vauthey JN
    Ann Surg; 2023 May; 277(5):813-820. PubMed ID: 35797554
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial cancer.
    Inoue S; Sassa N; Kawanishi H; Yuguchi Y; Suzuki T; Nagayama J; Matsui H; Miyata Y; Soeda Y; Tochigi K; Yamauchi Y; Maeda M; Kobayashi I; Hattori R; Matsukawa Y; Kato M
    Anticancer Res; 2022 Jul; 42(7):3627-3636. PubMed ID: 35790259
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting smad4.
    Sun C; Shi C; Duan X; Zhang Y; Wang B
    Bioengineered; 2022 Mar; 13(3):5915-5927. PubMed ID: 35199612
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Asiatic Acid Encapsulated Exosomes of Hepatocellular Carcinoma Inhibit Epithelial-Mesenchymal Transition Through Transforming Growth Factor Beta/Smad Signaling Pathway.
    Chen T; Zhu C; Wang X; Pan Y; Huang B
    J Biomed Nanotechnol; 2021 Dec; 17(12):2338-2350. PubMed ID: 34974857
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic Stratification of Resectable Colorectal liver Metastasis Patients and Implications for Adjuvant Therapy and Survival.
    Ecker BL; Shin P; Saadat LV; Court CM; Balachandran VP; Chandwani R; Drebin JA; Jarnagin WR; Kingham TP; Soares KC; Vakiani E; Wei AC; Kemeny NE; Smith JJ; Gonen M; D'Angelica MI
    Ann Surg; 2022 Feb; 275(2):371-381. PubMed ID: 34793355
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1.
    Bian X; Cao F; Wang X; Hou Y; Zhao H; Liu Y
    Sci Rep; 2021 Jun; 11(1):13122. PubMed ID: 34162944
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal liver Metastases.
    Nishioka Y; Kawaguchi Y; Kothari AN; Odisio BC; Vauthey JN
    J Gastrointest Surg; 2021 Jun; 25(6):1591-1600. PubMed ID: 33742360
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel approach for monitoring TGF-β signaling in vivo in colon cancer.
    Zhang BH; Wang C; Dong W; Chen X; Leng C; Luo X; Dong SL; Yin P; Zhang BX; Datta PK; Chen XP
    Carcinogenesis; 2021 Apr; 42(4):631-639. PubMed ID: 33367515
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients.
    Inoue S; Sassa N; Kato T; Yamauchi Y; Hirabayashi T; Yuguchi Y; Maeda M; Soeda Y; Hattori R; Gotoh M
    Int J Urol; 2020 Dec; 27(12):1116-1123. PubMed ID: 32924152
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Resection for pancreatic cancer metastases contributes to survival: A case report with sequential tumor genotype profiling during the long-term postoperative course.
    Sato H; Sasajima J; Okada T; Hayashi A; Kawabata H; Goto T; Koizumi K; Tamamura N; Tanabe H; Fujiya M; Chiba SI; Tanino M; Ono Y; Mizukami Y; Okumura T
    Medicine (Baltimore); 2020 Jun; 99(25):e20564. PubMed ID: 32569179
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells.
    Kim DH; Kim WD; Kim SK; Moon DH; Lee SJ
    Cell Death Dis; 2020 May; 11(5):406. PubMed ID: 32471991
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
    Montal R; Sia D; Montironi C; Leow WQ; Esteban-Fabró R; Pinyol R; Torres-Martin M; Bassaganyas L; Moeini A; Peix J; Cabellos L; Maeda M; Villacorta-Martin C; Tabrizian P; Rodriguez-Carunchio L; Castellano G; Sempoux C; Minguez B; Pawlik TM; Labgaa I; Roberts LR; Sole M; Fiel MI; Thung S; Fuster J; Roayaie S; Villanueva A; Schwartz M; Llovet JM
    J Hepatol; 2020 Aug; 73(2):315-327. PubMed ID: 32173382
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.